Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | GFER | P55789 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | CMA1 | P23946 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | MARS1 | P56192 | 1/20 | 0.36 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4832819 | 0.92 | ALDH1A1 (0.41) | ALDH1A1MEN1KMT2AGFERGAA | |
| SCHEMBL4841794 | 0.91 | GHSR (0.42) | ALDH1A1MEN1KMT2AGFERGAA | |
| SCHEMBL4843043 | 0.88 | ALDH1A1 (0.47) | ALDH1A1MEN1KMT2AGFERGAA | |
| SCHEMBL4833640 | 0.84 | GHSR (0.41) | ALDH1A1MEN1KMT2AGFERGAA | |
| SCHEMBL4842180 | 0.84 | PKM (0.40) | ALDH1A1KMT2APKM | |
| SCHEMBL4837892 | 0.83 | GHSR (0.41) | ALDH1A1MEN1KMT2AGFERGAA | |
| Hydrochloric Acid SCHEMBL4833643 | 0.82 | GHSR (0.41) | ALDH1A1MEN1KMT2AGFERGAA | |
| SCHEMBL4841989 | 0.82 | TRPA1 (0.37) | ALDH1A1MEN1KMT2AMAPTPKM | |
| SCHEMBL4836363 | 0.80 | MMP2 (0.41) | ALDH1A1MEN1KMT2AGFERGAA | |
| SCHEMBL4833202 | 0.80 | RORC (0.42) | MEN1KMT2AGAAMAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7465811-B2 | Indoline compounds | LABORATOIRES FOURNIER S.A. (FR) | 2008-12-16 | — | — | US | disclosed |
| US-20080119465-A1 | Novel Indoline Compounds | LABORATORIES FOURNIER S.A. (FR) | 2008-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080119465-A1 | Novel Indoline Compounds | GPR119, INSR, IRS1 | ALDH1A1 1819/4885MEN1 2712/4885KMT2A 1435/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.